Drug Type TCR therapy |
Synonyms |
Target |
Mechanism MBP modulators(Myelin basic protein modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization TeraImmune, Inc.Startup |
Active Organization TeraImmune, Inc.Startup |
Inactive Organization- |
Drug Highest PhaseEarly Phase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Sclerosis | Phase 1 | US | TeraImmune, Inc.Startup | 10 Feb 2022 |